Sweta Gupta

Researchers conducted a study to assess the effects of treatment with tocilizumab in patients hospitalized with COVID-19.

Researchers conducted a study to determine whether SARS-CoV-2 viral RNA detected in the bloodstreams of patients with COVID-19 is reflective of viremia or related to host immune responses and outcomes.

In a randomized clinical trial, researchers assessed the effectiveness of umifenovir in combination with other drugs for the treatment of patients hospitalized with moderate to severe COVID-19.

The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.

Researchers evaluated response to the COVID-19 vaccine in patients undergoing hemodialysis in light of the frequency of vaccine hyporesponsiveness in immunocompromised patients.

Study authors assessed whether azithromycin in addition to a hydroxychloroquine regimen shows positive results in clinical improvement or mortality reduction in patients hospitalized with severe COVID-19.

Continued use of glucocorticoids was associated with dose-dependent increase in the risk for serious infection, with small but significant risk for infection at low doses of 5 mg or less per day.

Immunity passport policies for COVID-19 should be communicated as stop-gap measures within wider, multipronged approaches to help society transition out of restrictive measures.

Polymicrobial prosthetic joint infections managed with surgical debridement, antibiotics and implant retention (DAIR) had high readmission rates and deep surgical site infections.

Investigators examined the risk for diabetes-related fracture in a multiethnic population.

Bone density at the hip declined twice as quickly in HIV-infected eomen vs men.

Bone ultrasonography was able to detect tenofovir-induced bone loss in patients with HIV.

Study finds that patients were 10% to 30% less likely to acquire a multidrug-resistant organism or C difficile if enhanced disinfection strategies were used in hospitals.

High cytomegalovirus titer is associated with mortality in patients with rheumatic disease.